Evidence map›Paper›PMID 42633237›Full record

ArticleInternational journal of particle therapy2026

A Target-Specific, "Eco-Friendly" Experimental Setup for Small Field Proton Irradiation.

Isabella Colizzi, Ylva Bornhauser, Antony J Lomax, David Meer, Serena Psoroulas

Abstract read
In one paragraph

Article in International journal of particle therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Isabella ColizziCenter for Proton Therapy, Paul Scherrer Institute, Villigen PSI, 5232 Switzerland.
Ylva BornhauserDepartment of Physics, ETH Zurich, Zurich, 8092 Switzerland.
Antony J LomaxCenter for Proton Therapy, Paul Scherrer Institute, Villigen PSI, 5232 Switzerland.
David MeerCenter for Proton Therapy, Paul Scherrer Institute, Villigen PSI, 5232 Switzerland.
Serena PsoroulasCenter for Proton Therapy, Paul Scherrer Institute, Villigen PSI, 5232 Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Increasing interest in proton FLASH radiotherapy has led to a focus on target-specific (TS) devices and passive scattering (PS) techniques. However, these techniques often require expensive, time-consuming custom devices like single-use collimators and compensators. Our study aims to improve this by creating a flexible TS-PS setup adaptable to various needs, specifically for small target structures. Methods: The collimating and compensating elements are made from 3D-printed polylactide containers filled with reusable copper or polypropylene spheres. We designed these TSPS elements using the modified Python package Porespy and conducted simulations in Tool for Particle Simulation Monte Carlo. We evaluated the collimator's performance by comparing a solid collimator with our proposed approach. As a feasibility study, we developed 2 "eco-friendly" PS setups for irradiating a simple spherical target and a complex small structure, a murine brain tumor. Results: We validated the computational model and MC simulations through depth dose curve and beam size measurements, demonstrating an agreement within a few percent. The "eco-friendly" collimators effectively collimated the beam, but we observed a dose halo at high energies due to protons not being stopped by the plastic bore; using higher-density materials can address this issue. We designed and validated the 2 "eco-friendly" setups via dose measurements and demonstrated that we could effectively compensate and collimate the beam to conform the dose to the target shape. The total time required to print the setup was under 45 minutes, and the filament cost was under $1. Conclusions: This innovative, "eco-friendly" approach using 3D printing allows for quick production of TS shapes, reducing waste and costs while enhancing conformity and improving the efficiency of PS treatments.

Indexed as

3D printingFLASHPassive scatteringPatient-specific

Identifiers

PMID42633237
PMCPMC13499423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.